Pedro Gonzalez-Cabrera, PhD, MS

Dr. Pedro J. Gonzalez-Cabrera obtained a Master of Science in Biology and a Doctor of Philosophy in Pharmacology from Creighton University. He completed his post-doctoral fellowship at the Cleveland Clinic and The Genomic Institute of the Novartis Research Foundation. His research focused on the molecular pharmacology of adrenergic and sphingolipid receptors. Dr. Gonzalez-Cabrera continued his research at The Scripps Research Institute from 2006 to 2017. He was involved in preclinical studies of immunomodulatory compounds for treating autoimmune diseases.

He co-reported a series of papers on fundamental discoveries that led to the development of Zeposia™, a small molecule therapeutic approved in the United States and Europe for the treatment of relapsing multiple sclerosis and inflammatory bowel disease. Dr. Gonzalez-Cabrera switched his career focus to education and was previously a lecturer at California State University, where he taught undergraduate biology and physiology courses. He joined the University of St. Augustine for Health Sciences in 2019 as an Assistant Professor in the Doctor of Physical Therapy Program.